T Scientific Statistics

Total Valuation

T Scientific has a market cap or net worth of KRW 86.92 billion. The enterprise value is 80.38 billion.

Market Cap	86.92B
Enterprise Value	80.38B

Important Dates

The next estimated earnings date is Thursday, August 14, 2025.

Earnings Date	Aug 14, 2025
Ex-Dividend Date	n/a

Share Statistics

T Scientific has 71.25 million shares outstanding. The number of shares has increased by 9.52% in one year.

Current Share Class	71.25M
Shares Outstanding	71.25M
Shares Change (YoY)	+9.52%
Shares Change (QoQ)	-0.43%
Owned by Insiders (%)	0.32%
Owned by Institutions (%)	0.20%
Float	47.76M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.13
PB Ratio	0.62
P/TBV Ratio	0.64
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-6.37
EV / Sales	1.97
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-8.96

Financial Position

The company has a current ratio of 1.87, with a Debt / Equity ratio of 0.06.

Current Ratio	1.87
Quick Ratio	1.55
Debt / Equity	0.06
Debt / EBITDA	n/a
Debt / FCF	-0.96
Interest Coverage	-17.11

Financial Efficiency

Return on equity (ROE) is -8.66% and return on invested capital (ROIC) is -4.24%.

Return on Equity (ROE)	-8.66%
Return on Assets (ROA)	-3.55%
Return on Invested Capital (ROIC)	-4.24%
Return on Capital Employed (ROCE)	-7.14%
Revenue Per Employee	196.27M
Profits Per Employee	-60.62M
Employee Count	208
Asset Turnover	0.22
Inventory Turnover	56.77

Taxes

Income Tax	-981.28M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +13.68% in the last 52 weeks. The beta is -0.12, so T Scientific's price volatility has been lower than the market average.

Beta (5Y)	-0.12
52-Week Price Change	+13.68%
50-Day Moving Average	976.74
200-Day Moving Average	999.08
Relative Strength Index (RSI)	62.62
Average Volume (20 Days)	3,421,462

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, T Scientific had revenue of KRW 40.82 billion and -12.61 billion in losses. Loss per share was -180.76.

Revenue	40.82B
Gross Profit	10.67B
Operating Income	-10.56B
Pretax Income	-13.41B
Net Income	-12.61B
EBITDA	-9.21B
EBIT	-10.56B
Loss Per Share	-180.76

Full Income Statement

Balance Sheet

The company has 15.24 billion in cash and 8.63 billion in debt, giving a net cash position of 6.60 billion or 92.69 per share.

Cash & Cash Equivalents	15.24B
Total Debt	8.63B
Net Cash	6.60B
Net Cash Per Share	92.69
Equity (Book Value)	140.62B
Book Value Per Share	1,972.92
Working Capital	13.42B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -8.93 billion and capital expenditures -39.41 million, giving a free cash flow of -8.97 billion.

Operating Cash Flow	-8.93B
Capital Expenditures	-39.41M
Free Cash Flow	-8.97B
FCF Per Share	-125.89

Full Cash Flow Statement

Margins

Gross margin is 26.14%, with operating and profit margins of -25.88% and -30.88%.

Gross Margin	26.14%
Operating Margin	-25.88%
Pretax Margin	-32.85%
Profit Margin	-30.88%
EBITDA Margin	-22.55%
EBIT Margin	-25.88%
FCF Margin	n/a

Dividends & Yields

T Scientific does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-9.52%
Shareholder Yield	n/a
Earnings Yield	-14.51%
FCF Yield	-10.32%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

T Scientific has an Altman Z-Score of 1.51 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.51
Piotroski F-Score	4